Integrity Solutions

APRIL 17, 2025

In stable markets, as our businesses are growing, investing in sales training is a relatively standard part of the acceleration process. Once you find the right type of training to support your team and culture, your company hits the “go” button and it’s full speed ahead. Fueled both by the skills and confidence of the team and a predictable, healthy external environment, the payoff comes relatively quickly in the form of higher productivity, quota attainment and overall revenu

Sales 130

Sales Training Marketing Prospecting 130

MedCity News

APRIL 18, 2025

Robert F. Kennedy Jr.s rise to become secretary of the Department of Health and Human Services has some concerned that anti-vaccine policies are coming. If the nations top public health agency pulls support of vaccination, other healthcare stakeholders will need to step up to fill the vaccine messaging void. The post How the Health Sector Can Change Vaccine Messaging Amid Rising Anti-Vaccine Sentiment appeared first on MedCity News.

Healthcare 303

Healthcare Healthcare FDA Physicians 303

PharmaVoice

APRIL 18, 2025

Compass Pathways expects to publish the first phase 3 results from a large-scale, psilocybin drug trial by the end of this quarter.

278

278

European Pharmaceutical Review

APRIL 17, 2025

Over the past decade, we have witnessed the arrival of a new era in biopharmaceutical R&D. Traditional methods and processes, such as wet labs, are being augmented by a rapidly expanding digital ecosystem in pharma. Across the industry, this shift is offering extraordinary opportunities to increase the speed, accuracy, and reproducibility of research.

Pharma 76

Pharma Training Pharmaceutical Leads 76

Advertiser: ZoomInfo

AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.

Sales

Pharma Marketing Network

APRIL 16, 2025

Imagine launching a brand campaign without guessworkwhere your message reaches the right healthcare professional at the right time on the right channel. Thats the promise of data-driven marketing , a strategy thats rapidly transforming how pharmaceutical companies approach promotion, education, and engagement in 2025. As privacy regulations evolve, customer expectations change, and AI-driven technologies emerge, pharma marketers must adapt or risk becoming irrelevant.

Marketing 59

Marketing Pharma Prescription Networking 59

PharmaVoice

APRIL 16, 2025

Lower operating costs and a supply of high-skilled workers are helping the North Carolina region pull in billions of pharma manufacturing investments.

Manufacturing 252

Manufacturing Pharma 252

European Pharmaceutical Review

APRIL 14, 2025

New research has proposed a method to increase the effectiveness of tumour-infiltrating lymphocyte (TIL) immunotherapy. Investigators identified that the natural immune protein called CD40L was key in improving TIL cultures in the lab. We discovered that by adding CD40L to the immune cells in the lab, we could dramatically improve the number and quality of cancer-fighting T cells were able to grow, explained Daniel Abate-Daga, PhD, lead author of the study and Scientific Director of the Cell The

Manufacturing 59

Manufacturing Leads Pharmaceutical Patients 59

Pharma Marketing Network

APRIL 17, 2025

What do you do when the traditional pillars of your marketing strategy start to crumble? For many pharmaceutical companies in 2025, the answer is clear: pivot aggressively toward digital. With geopolitical volatility sparking new tariff threats and mounting legislative scrutiny over pharmaceutical television ads, pharma digital ad spend is experiencing a noticeable surge.

Pharma 59

Pharma Networking Marketing Media 59

MedCity News

APRIL 13, 2025

At Medicarians 2025, MedCity News Editor-in-Chief Arundhati Parmar explored the state of AgeTech venture capital with three investors. The panelists agreed that despite growing clear opportunities, the AgeTech market currently lacks the dedicated funding, proven business models and major success stories needed for it to take off. The post Where Does AgeTech Investment Stand?

Marketing 269

Marketing 269

Speaker: Jesse Hunter and Brynn Chadwick

Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.

Sales

PharmaVoice

APRIL 14, 2025

Major changes to the dynamics of the pharmaceutical ecosystem are making executive decisions even tougher.

Pharmaceutical 223

Pharmaceutical 223

European Pharmaceutical Review

APRIL 17, 2025

Researchers in Spain have developed a new method to deliver cell therapies to patients on extracorporeal membrane oxygenation (ECMO), a life support system for severe lung failure. The consecutive intrabronchial administration (CIBA) method enables a new route of delivery: targeted, controlled, fractionated intrabronchial delivery. The researchers referred to the novel approach as slow consecutive intrabronchial lobe-by-lobe administration.

Patients 59

Patients Pharmaceutical 59

Curzon Consulting

APRIL 17, 2025

The issue Shrinking customer base 13 legacy books and numerous policy variants causing customer and staff confusion Operationally complex to manage high cost to serve Existing proposition and pricing created trigger points for customer exit Customers not segmented by value No differentiated renewal or save strategies Not pricing for risk or maximised value retention Poor customer journey: passed from function to function, advisors not empowered Solution Designed and executed a pricing, product

Insurance 52

Insurance Engineering Management Leads 52

MedCity News

APRIL 13, 2025

Even as studies and personal experiences repeatedly reflect the effectiveness of MOUD, a stigma about this approach and the medication persists, complicating efforts to help more people treat their opioid use disorders. The post Stigma Against Addiction Medication Limits Our Ability to End the Opioid Epidemic appeared first on MedCity News.

Medical 262

Medical Patients Biopharma Pharma 262

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

PharmaVoice

APRIL 17, 2025

The non-traditional marketing approach comes amid a potential crackdown on TV drug ads.

Marketing 147

Marketing 147

Pharma Marketing Network

APRIL 16, 2025

If your brand still views content as a checkbox for SEO or a static digital asset, you’re already falling behind. In the ever-evolving healthcare landscape, especially in 2025, content marketing strategies have moved from optional to mission-critical for pharma brands. But not just any content will do. Today, successful campaigns are dynamic, identity-driven, omnichannel, and personalized.

Marketing 52

Marketing Pharma Networking Education 52

Curzon Consulting

APRIL 17, 2025

The issue Frontline ‘negotiators’ not trained – Teams lacked clarity on effective, strategic negotiations Power balance leaning to suppliers – Although the airport had leverage, suppliers secured favourable contract terms Costs above benchmark – Costs were identifed as 20% to 40% above benchmark for critical success Solution Benchmarking & Research Gained clarity on the as-is situation.

Training 52

Training Insurance Management Engineering 52

MedCity News

APRIL 18, 2025

How can physicians and patients be confident enough that vendors entirely ignorant of the FDA process for repair and reporting can properly recalibrate life-saving machines? Is this really the right place to argue that anyone can do it? The post Medical Device Right to Repair is the Wrong Approach appeared first on MedCity News.

Medical 269

Medical Physicians FDA Patients 269

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

European Pharmaceutical Review

APRIL 16, 2025

The European Commission (EC) has granted a marketing authorization for Leqembi (lecanemab) as the first therapy in the EU targeting an underlying cause of Alzheimers. Eisai Co., Ltd. and Biogen Inc.s amyloid-beta (A) monoclonal antibody is indicated for adults with mild cognitive impairment and mild dementia due to Alzheimers who are apolipoprotein E 4 (ApoE 4*) non-carriers or heterozygotes with confirmed amyloid pathology.

Patients 52

Patients Medicine Marketing Leads 52

Pharma Marketing Network

APRIL 12, 2025

Ever wonder why some pharma brands dominate the top of search results while others get buried? It’s not just luck or big budgetsits strategy. Imagine a doctors waiting room filled with brochures; only a few stand out. The same principle applies to search engine results. Standing out in pharma requires more than compliant messaging; it demands visibility.

Marketing 52

Marketing Pharma Engineering Networking 52

Curzon Consulting

APRIL 17, 2025

The issue Frontline ‘negotiators’ not trained – Teams lacked clarity on effective, strategic negotiations Power balance leaning to suppliers – Although the airport had leverage, suppliers secured favourable contract terms Costs above benchmark – Costs were identifed as 20% to 40% above benchmark for critical success Solution Benchmarking & Research Gained clarity on the as-is situation.

Training 52

Training Insurance Management Engineering 52

MedCity News

APRIL 17, 2025

The first Phase 3 results for Eli Lillys daily pill orforglipron show statistically significant reductions in blood sugar and body weight in patients with type 2 diabetes. The pharmaceutical giant plans global regulatory submissions starting at the end of this year. The post Eli Lillys Metabolic Medicine Takes the Lead in the Race to Develop an Oral GLP-1 Drug appeared first on MedCity News.

Medicine 235

Medicine Leads Pharmaceutical Patients 235

Advertiser: ZoomInfo

ZoomInfo customers aren’t just selling — they’re winning. Revenue teams using our Go-To-Market Intelligence platform grew pipeline by 32%, increased deal sizes by 40%, and booked 55% more meetings. Download this report to see what 11,000+ customers say about our Go-To-Market Intelligence platform and how it impacts their bottom line. The data speaks for itself!

Marketing

PharmaVoice

APRIL 15, 2025

Brian Thompson’s murder has raised questions about the cost of U.S. healthcare, embroiling insurers, drugmakers and PBMs in a battle for the future of the industry.

Insurance 130

Insurance Healthcare Healthcare 130

European Pharmaceutical Review

APRIL 15, 2025

New recommendations issued by the EMA and the Heads of Medicines Agencies (HMA), through the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) , aim to address supply chain vulnerabilities for radiopharmaceutical medicines. Occasional shortages of radiopharmaceuticals have emerged in different EU Member States, due to disparity between manufacturing capacity and demand, according to the EMA.

Medicine 52

Medicine Transportation Medical Safety 52

Curzon Consulting

APRIL 17, 2025

The issue Our clients was experiencing significant changes in the largest customer segment Leading to a material decline in client revenues EBITDA fell below business case targets Solution Sized the UK medical consumables market for 10 segment, including private acute, NHS, care homes Created a vision for the organisation in collaboration with theclient senior leadership team Shortlisted target segments to drive organic growth Developedwin strategies and business model options for each segment I

Insurance 52

Insurance Marketing Leads Medical 52

MedCity News

APRIL 13, 2025

The combination of Bristol Myers Squibb cancer drugs Opdivo and Yervoy landed FDA approvals for the first-line treatment of colorectal cancer and hepatocellular carcinoma. Several other products also expanded their approved uses in our recap of recent regulatory news. The post BMS Immunotherapy Combo Gets Two FDA Nods for GI Cancers in Span of a Week appeared first on MedCity News.

FDA 274

FDA Biopharma Pharma 274

Speaker: Kevin Burke

AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.

Sales

Pharma Marketing Network

APRIL 18, 2025

The pace of transformation in healthcare marketing has accelerated dramatically in recent years. As we dive deeper into 2025, the convergence of digital technology, patient-centric strategies, and precision targeting is redefining how pharma brands communicate with both healthcare professionals and patients. No longer is it enough to rely on traditional outreach methods or static content campaigns.

Healthcare 52

Healthcare Healthcare Marketing Pharma 52

European Pharmaceutical Review

APRIL 18, 2025

Eli Lilly and Company has announced positive topline results for the first oral small molecule glucagon-like peptide-1 (GLP-1) receptor agonist , taken without food and water restrictions, to successfully complete a Phase III trial. “ ACHIEVE-1 is the first of seven Phase III studies examining the safety and efficacy of orforglipron across people with diabetes and obesity.

Safety 52

Safety Medicine Consulting Food 52

Vodori

APRIL 17, 2025

Marketing in life sciences comes with more oversight, more risk, and more steps than most industries. Every claim needs substantiation, every asset requires approval, and every channelwhether digital, print, or socialmust meet strict global regulations. Add siloed teams and disconnected systems, and its no surprise that promotional review becomes a bottleneck.

Marketing 52

Marketing 52